Trial intelligence / Profile preview

Hyperbaric Oxygen Therapy in Chronic Arm Lymphedema After Radiotherapy for Cancer

NCT00077090Phase 2Unknown

Sponsor
The Institute of Cancer Research
Start
Apr 2004
Modality
NPI (Non-Pharmacological Intervention)
Countries
1
01

Overview

A Phase 2 trial of hyperbaric oxygen therapy in lymphedema, sponsored by The Institute of Cancer Research. Status: unknown.

02

Drugs

hyperbaric oxygen therapy
03

Conditions

lymphedema

Beyond the preview

Go deeper on NCT00077090.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00077090.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call